Outcome of Baerveldt glaucoma implant for neovascular glaucoma Satoshi Kobayashi 1 , Kumi Takemae 1 , Sachiko Sugiyama 1 1Department of Ophthalmology, Yokohama Hodogaya Central Hospital pp.859-863
Published Date 2016/6/15
DOI https://doi.org/10.11477/mf.1410211834
  • Abstract
  • Look Inside
  • Reference

Abstract Purpose: To report the outcome of Baerveldt glaucoma implant in eyes with neovascular glaucoma.

Cases and Method: This retrospective study was made on 27 eyes of 25 cases that received Baerveldt implant in the past 3 years. The series comprised 19 male and 8 female eyes. The age ranged from 29 to 82 years, average 61 years. Neovascular glaucoma was secondary to diabetic retinopathy in 23 eyes, central retinal vein occlusion in 3 eyes, and branch retinal vein occlusion in one eye. All the eyes showed rubeosis in the iris or chamber angle. Prior surgery, including vitrectomy, had been performed in 22 eyes. Cases were followed up for over 6 months and average of 17 months after implantation. Surgery was judged as success when intraocular pressure(IOP)was kept between 5 and 21 mmHg.

Results: IOP averaged 36.2±11.4 mmHg before surgery, 11.1±3.8 mmHg one year after surgery, and 12.3±4.5 mmHg two years after surgery. The difference was significant. Cumulative rate of success was 90.1% one year and 90.1% two years after surgery. Within one month after surgery, hyphema developed in 7 eyes, vitreous hemorrhage in 2 eyes, and choroidal detachment in 2 eyes. Corneal endothelial cell density decreased by 30% or over after one month of surgery.

Conclusion: Implantation of Baerveldt glaucoma implant was successful in 90% of eyes with neovascular glaucoma.

Copyright © 2016, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院